The USFDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on June 15th 2023, to discuss and make recommendations on the selection of strain(s) to be included in the periodic updated COVID-19 vaccines for the 2023-2024 vaccination campaign. This discussion will include consideration of the vaccine composition for fall to winter, 2023-2024.
Back to All Events
Earlier Event: June 9
Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
Later Event: June 28
Endocrinologic Drugs Advisory Committee